Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer
By: Ana Vodusek, Srdjan Novakovic, Vida Stegel and Berta Jereb
Open Access
|Sep 2011References
- Jazbec J, Todorovski L, Jereb B. Classification tree analysis of second neoplasms in survivors of childhood cancer.2007;: 1-6.
- Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.2000;: 2435-43.
- Boussen H, Kochbati L, Besbes M, Dhiab T, Makhlouf R, Jerbi G, et al. [Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature]. [French].2000;: 465-8.
- Ozet A, Yavuz AA, Kömürcü S, Oztürk B, Safali M, Arpaci F, et al. Bilateral male breast cancer and prostate cancer: a case report.2000;: 188-90.
- Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer.2005;: 20-26.
- Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men.2002;: 678-87.
- Leinung S, Horn LC, Backe J. [Male breast cancer: history, epidemiology, genetic and histopathology]. [German].2007;: 379-85.
- Murata H, Khattar NH, Gu L, Li GM. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer.2005;: 143-50.
- Latz D, Alfrink M, Nassar N, Beyerle C. Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation.2004;: 477-9.
- Zebic-Sinkovec M, Kadivec M, Podobnik G, Skof E, Snoj M. Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report.2010;: 228-31.
- Thomas DB, Rosenblatt K, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, et al. Ionizing radiation and breast cancer in men (United States).1994;: 9-14.
- Eeles RA. Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.2000;: 283-90.
- Malkin D. The role of p53 in human cancer.2001;: 231-43.
- Zager V, Cemazar M, Hreljac I, Lah TT, Sersa G, Filipic M. Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression.2010;: 42-51.
- Cesar Paz-y-Mino, Perez CJ, Fiallo BF, Leone PE. A polymorphism in thegene (gIVS12-6T>C) associated with non-Hodgkin lymphomas.2002;: 29-33.
- Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP, et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents.2003;: 3012-20.
- Ollila S, Delmadi Bebek D, Jiricny J, Nystrom M. Mechanisms of pathogenicity in human MSH2 missense mutants.2008:: 1355-63.
Language: English
Page range: 296 - 299
Published on: Sep 22, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2011 Ana Vodusek, Srdjan Novakovic, Vida Stegel, Berta Jereb, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.